A CRISPR treatment for hereditary angioedema significantly reduced swelling attacks in its first human trial.
One-shot CRISPR treatment for inherited disease aces first human trial
Posted in biotech/medical
Posted in biotech/medical
A CRISPR treatment for hereditary angioedema significantly reduced swelling attacks in its first human trial.